20/20 Biolabs is trading at $0.66 (+8.69%), extending its recent advance after closing at $0.62 on August 27 and $0.56 on August 26.
- No company announcement dated August 27 or August 28 was identified, and available coverage does not explicitly link the move to a specific release.
- The September 2 investor webinar and August 17 quarterly update remain the latest company developments, but neither is confirmed as today’s catalyst.